1. Levin VA, Wilson CB: Nitrosourea chemotherapy for primary malignant gliomas. Cancer Treat Rep 60: 719?724, 1976
2. Bodell WJ, Gerosa M, Aida T, Berger MS, Rosenblum ML: Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res 45: 3460?3464, 1985
3. Satoh MS, Huh N, Horie Y, Thomale J, Rajewsky MF, Kuroki T: Acquisition of resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in V79 cells through increased removal of O6-alkylguanine. Jpn J Cancer Res 78: 1094?1099, 1987
4. Bodell WJ, Tokuda K, Ludlum DB: Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea. Cancer Res 48: 4489?4492, 1988
5. Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M: Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains. Acta Neurochir (Wien) 103: 62?66, 1990